Search results

  1. E

    Observational Study of Repeat Immunoadsorption in Post-COVID ME/CFS Patients with Elevated Beta-2-Adrenergic Receptor Autoantibodies,2023, Stein et al

    Thank you for the response. A bit dissapointing that Hand grip strength, which played a bigger role in her new study as prognostic marker...
  2. E

    Observational Study of Repeat Immunoadsorption in Post-COVID ME/CFS Patients with Elevated Beta-2-Adrenergic Receptor Autoantibodies,2023, Stein et al

    For the immunologists on this forum: Can anybody explain a more precise hypothesis why exactly Obinutuzumab is what Scheibenbogen is planning to accompany her Immunadsorption study with? From what I've understood Obinutuzumab is something like "the new Rituximab", with possibly some advantages...
  3. E

    Preprint SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptide,

    SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptide Abstract An increasing number of reports suggest an association between COVID-19 infection and initiation or acceleration of neurodegenerative...
  4. E

    Hypothesis Long COVID as a functional somatic symptom disorder caused by abnormally precise prior expectations during Bayesian perceptual processing, 2023, Joffe

    Now that's funny. Didn't patients have to come up with the name Long-Covid because it was a new phenomenon nobody knew of and nobody was writing about, a community of patients meeting on Twitter? Did they believe in a disease that they didn't believe in? Now that news and scientists have started...
  5. E

    Temporal pathway analysis of cerebrospinal fluid proteome in herpes simplex encephalitis, 2023, Nääs, Bergquist, Xiao et al

    Temporal pathway analysis of cerebrospinal fluid proteome in herpes simplex encephalitis ABSTRACT Objectives: We examined the temporal changes of the CSF proteome in patients with herpes simplex encephalitis (HSE) during the course of the disease, in relation to anti-N-methyl-D-aspartate...
  6. E

    Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization, 2023, Taquet et al

    A lot oft the big newspaper agencies have written something about the study. Science also wrote a piece https://www.science.org/content/article/clotting-proteins-linked-long-covid-s-brain-fog.
  7. E

    Haunting innate immune memories of COVID-19, 2023, Birgit Sawitzki

    Haunting innate immune memories of COVID-19 In addition to acute hyperinflammatory responses, SARS-CoV-2 infections can have long-term effects on our immune system leading to, for example, post-acute sequelae of COVID-19 (PASC). In this issue of Cell, Cheong et al. show that severe infections...
  8. E

    Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization, 2023, Taquet et al

    Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization Abstract Post-COVID cognitive deficits, including ‘brain fog’, are clinically complex, with both objective and subjective components. They are common and debilitating, and can affect the...
  9. E

    Preprint SARS-CoV-2 RNA Persists in the Central Nervous System of Non-Human Primates Despite Clinical Recovery, 2023, Booze et al

    SARS-CoV-2 RNA Persists in the Central Nervous System of Non-Human Primates Despite Clinical Recovery Abstract Adverse neurological and psychiatric outcomes, collectively termed the post-acute sequelae of SARS-CoV-2 infection (PASC), persist in adults clinically recovered from COVID-19...
  10. E

    A synthetic data generation system for myalgic encephalomyelitis/chronic fatigue syndrome questionnaires 2023,Lacasa et al

    “Therefore, each subject to be diagnosed with ME/CFS must undergo a Fukuda criteria evaluation and procedure that each unit has established using batteries of validated self-administered questionnaires. “ “Patients were eligible to participate if they were 18 years, had a confirmed diagnosis of...
  11. E

    Characteristics and Treatment of Exercise Intolerance in Patients With Long COVID, 2023, Edward et al

    I remember when I went from full time working and high level athlete to fully bedbound within one night. I guess I just shouldn't have deconditioned so hard in that one night.
  12. E

    Dissecting human population variation in single-cell responses to SARS-CoV-2, 2023, Quintana-Murci et al

    Dissecting human population variation in single-cell responses to SARS-CoV-2 Abstract Humans display substantial interindividual clinical variability after SARS-CoV-2 infection1,2,3, the genetic and immunological basis of which has begun to be deciphered4. However, the extent and drivers of...
  13. E

    Violation of the Dutch Code of Ethics for Psychologists with current CFS guideline, 2023, Bloks & Khouri

    The Netherlands seems to be the Wild West in terms of naming conventions. The BPS group calls it CVS and uses psychological criteria to diagnose it and then manipulates ME/CFS studies with that, they couldn't care less about guidelines. Then there's a misguided adovacy group that believes that...
  14. E

    Nirmatrelvir/ritonavir and risk of long COVID symptoms: A retrospective cohort study, 2023, Congdon et al

    Results contradict the previous study https://doi.org/10.1001/jamainternmed.2023.0743 discussed here https://www.s4me.info/threads/association-of-treatment-with-nirmatrelvir-and-the-risk-of-post–covid-19-condition-2023-yan-xie-phd-et-al.32483/#post-466630. However, the sample size is extremely...
  15. E

    Nirmatrelvir/ritonavir and risk of long COVID symptoms: A retrospective cohort study, 2023, Congdon et al

    Nirmatrelvir/ritonavir and risk of long COVID symptoms: A retrospective cohort study We conducted a retrospective cohort study to assess whether treatment with nirmatrelvir/ritonavir was associated with a reduced risk of long COVID. We enrolled 500 adults with confirmed SARS-CoV-2 who were...
  16. E

    Reactivated endogenous retroviruses promote protein aggregate spreading, 2023

    Reactivated endogenous retroviruses promote protein aggregate spreading Abstract Prion-like spreading of protein misfolding is a characteristic of neurodegenerative diseases, but the exact mechanisms of intercellular protein aggregate dissemination remain unresolved. Evidence accumulates...
  17. E

    Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model 2023 Turner et al

    Haven't read anything of the study apart from the first word, which has been misspelled.
  18. E

    Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model 2023 Turner et al

    A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model HIGHLIGTS Imaging flow cytometry utilizing a novel rapid flow cytometric detection method is a promising method for detecting amyloid fibrin(ogen) microclots in conditions associated with...
  19. E

    Muscle abnormalities worsen after post-exertional malaise in long COVID, 2023/4, Wüst, van Vugt, Appelman et al

    Agreed. I wanted to mention that all these patients seem to still be fit enough to partially work (at least that was the case for IDO2 study), were at least fit enough for hospital appointments 3 days in a row along with a bicycle test and have had Long-Covid for less than 1.5 years, so...
Back
Top